All News

Round 2 of study finds a reduction in start time of antiretroviral therapy for HIV treatment.

Treatment with Accolate or Singulair could prevent influenza pneumonia infections.

Patients with diabetes in middle age were 77% more likely to develop dementia.

The American Society of Clinical Oncology (ASCO) released a clinical practice guideline on human papillomavirus (HPV) vaccination for the primary prevention of cervical cancer.

TP53 alteration seen among 49% of patients receiving first-line treatment for renal cell carcinoma.

Test delivers the results of a multiple sclerosis diagnosis in as few as 7 days.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

The American Heart Association (AHA) has published a new science advisory stating that there is not enough evidence to support the use of fish oil supplementation as a primary prevention of cardiovascular disease in the general population.

The antidote to stress is finding humor and counting our blessings.

Pharmacy school graduation is right around the corner, and it is definitely a time for celebration.

Although dolutegravir (DTG) is known for its high genetic barrier to resistance, its durability to maintain virologic suppression had not previously been evaluated.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

Physicians in small practices will receive education and training to ensure success in the Quality Payment Program.

Patients who take long-acting opioids are more likely to experience chronic opioid use, a report published in the CDC’s Morbidity and Mortality Weekly Report has determined.

Pembrolizumab (Keytruda) seen to improve overall response rate in patients with classical Hodgkin lymphoma.

States are encouraged to pursue insurance initiatives that increase affordablity.

FDA’s Center for Drug Evaluation and Research will focus on the 21st Century Cures Act and the drug review process.

Walking regularly could boost overall health in patients undergoing cancer treatment.

The PCSK9 inhibitor dramatically reduces high cholesterol and cuts the risk of heart attack and stroke.

The Blueprint for Transparency at the FDA provides 18 recommendations for the release of regulatory information and data.

A lack of IRS-1 expression observed to increase cell proliferation in blood vessels of the heart.

Researchers analyzed tumors and treated them with a targeted therapy.

Study is the first to examine the function of SP140 protein in inflammatory diseases.

A new study published in the Journal of the American Pharmacists Association analyzed the use of the “#pharmacist” tag on Instagram.

Insulin could become a new therapeutic option for HIV-associated neurocognitive disorders.

Top news of the day from across the health care landscape.

An infection drug was seen to regenerate sperm production in patients with cancer.

A combination drug regimen may be the answer to treating acute myeloid leukemia.